Generic Drugs

Dec 19, 2016
By Pharmaceutical Technology Editors
A pilot project, beginning in 2017, will support the development of biosimilars.
Nov 02, 2016
The biosimilar pathway permits licensure based on less than full clinical data.
Nov 02, 2016
Pharmaceutical Technology
Reliable, high-quality products require innovative analytics and production.
Oct 04, 2016
By Pharmaceutical Technology Editors
Xellia added laboratory space and personnel in Zagreb, Croatia to work on anti-infective products that combat the antimicrobial resistance problem.
Sep 30, 2016
By Pharmaceutical Technology Editors
Ravi Limaye gives an overview of the biosimilar industry and projects for 2020.
Sep 29, 2016
By Pharmaceutical Technology Editors
Containing costs and improving compliance will be crucial to ensuring the growth of generic pharmaceuticals in the future, says Dilip Shah, CEO of Vision Consulting Group, in CPhI’s 2016 Annual Report, which will be formally issued at CPhI 2016 in Barcelona.
Sep 29, 2016
By Pharmaceutical Technology Editors
Alan Sheppard, Principal, Global Generics at IMS Health and CPhI expert panel member, discusses generic medicine opportunities in the 2016 CPhI Annual Industry Report.
Sep 26, 2016
By Pharmaceutical Technology Editors
The agency approves Amjevita (adalimumab-atto) for the treatment of inflammatory diseases.
Sep 22, 2016
By Pharmaceutical Technology Editors
The agency published the guidance to help generic-drug facilities comply with the GDUFA self-identification requirement.
Sep 12, 2016
Concerns have emerged that continued growth in the biosimilars market could be limited by mounting pressure to push down on prescription drug outlays.
native1_300x100
lorem ipsum